Skip Nav Destination
Venetoclax–Obinutuzumab Elicits High Response Rates in CLL
Cancer Discov (2019) 9 (5): OF5.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Rui Tang
- Jiangfan Yu
- Yaqian Shi
- Puyu Zou
- Zhuotong Zeng
- Bingsi Tang
- Yaoyao Wang
- Guanghui Ling
- Mei Luo
- Rong Xiao
International Immunopharmacology (2020) 83: 106389.